@article{63fb8d7b170a4e70845fcaa432bb50e2,
title = "Emerging Medical Treatments for Meningioma in the Molecular Era",
keywords = "World Health Organization (WHO), Grade I, II, and III Meningiomas, High Grade Meningiomas (HGMs), tumor heterogeneity, genetic subtypes, overall survival (OS), progression free survival (PFS), targeted therapy, clinical trials, oncolytic virus (OV), TERT PROMOTER MUTATIONS, GROWTH-FACTOR RECEPTOR, FOCAL-ADHESION KINASE, TUMOR-SUPPRESSOR GENE, HERPES-SIMPLEX-VIRUS, SKULL BASE MENINGIOMAS, OF-THE-LITERATURE, PHASE-II TRIAL, INTEGRATIVE GENOMIC ANALYSIS, PLECKSTRIN HOMOLOGY DOMAIN, RECURRENT MENINGIOMAS, SONIC HEDGEHOG PATHWAY",
author = "Fares Nigim and Hiroaki Wakimoto and Kasper, {Ekkehard M.} and Linda Ackermans and Yasin Temel",
year = "2018",
month = sep,
day = "1",
doi = "10.3390/biomedicines6030086",
language = "English",
volume = "6",
journal = "Biomedicines",
issn = "2227-9059",
publisher = "MDPI AG",
number = "3",
}